Back to Search
Start Over
Postoperative Dexamethasone Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis
- Source :
- The Journal of bone and joint surgery. American volume. 102(20)
- Publication Year :
- 2020
-
Abstract
- BACKGROUND Surgeons have hesitated to use steroids in patients undergoing posterior spinal fusion because of the risk of wound complications. The literature has supported the use of postoperative steroids in other areas of orthopaedics on the basis of more rapid recovery and improved postoperative pain control. We hypothesized that a short course of postoperative dexamethasone following posterior spinal fusion for the treatment of adolescent idiopathic scoliosis (AIS) would decrease opioid usage without increasing wound-healing problems. METHODS Consecutive patients undergoing posterior spinal fusion for the treatment of AIS from 2015 to 2018 at a single hospital were included. A review of demographic characteristics, curve characteristics, surgical data, and postoperative clinic notes was performed. Opioid usage was determined by converting all postoperative opioids given into morphine milligram equivalents (MME). RESULTS Sixty-five patients underwent posterior spinal fusion for the treatment of AIS without postoperative steroids (the NS group), and 48 patients were managed with 3 doses of postoperative steroids (the WS group) (median, 8.0 mg/dose). There was no difference between the groups in terms of curve magnitude, number of vertebrae fused, or estimated blood loss. There was a 39.6% decrease in total MME used and a 29.5% decrease in weight-based MME used in the group receiving postoperative steroids (82.0 mg [1.29 mg/kg] in the NS group versus 49.5 mg [0.91 mg/kg] in the WS group]; p < 0.001). This difference persisted after accounting for gabapentin, ketorolac, and diazepam usage; surgical time; curve size; levels fused; and number of osteotomies (median decrease, 0.756 mg/kg [95% CI, 0.307 to 1.205 mg/kg]; p = 0.001). Three patients in the NS group (4.6%) and 4 patients in the WS group (8.3%) developed wound dehiscence requiring wound care (p = 0.53). One patient in the NS group required surgical debridement for the treatment of an infection. Patients in the WS group were more likely to walk at the time of the initial physical therapy evaluation (60.4% versus 35.4%; p = 0.013). CONCLUSIONS A short course of postoperative steroids after posterior spinal fusion was associated with a 40% decrease in the use of opioids, with no increase in wound complications. Surgeons may consider the use of perioperative steroids in an effort to decrease the use of postoperative opioids following posterior spinal fusion for the treatment of AIS. LEVEL OF EVIDENCE Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- Subjects :
- Male
medicine.medical_specialty
Adolescent
medicine.medical_treatment
Dexamethasone
medicine
Humans
Orthopedics and Sports Medicine
Glucocorticoids
Retrospective Studies
Postoperative Care
Pain, Postoperative
Wound Healing
business.industry
Wound dehiscence
General Medicine
Perioperative
medicine.disease
Ketorolac
Analgesics, Opioid
Spinal Fusion
Opioid
Scoliosis
Anesthesia
Spinal fusion
Case-Control Studies
Orthopedic surgery
Morphine
Surgery
business
medicine.drug
Subjects
Details
- ISSN :
- 15351386
- Volume :
- 102
- Issue :
- 20
- Database :
- OpenAIRE
- Journal :
- The Journal of bone and joint surgery. American volume
- Accession number :
- edsair.doi.dedup.....728e95bd5e85e4f56371e7adcf06958e